Both CD4+ FoxP3+ and CD4+ FoxP3− T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro-Reference-Cited by-同舟云学术

Both CD4+ FoxP3+ and CD4+ FoxP3− T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro

Published:2011-04-05 Issue:3 Volume:133 Page:296-306
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:

Author:

Lindqvist Camilla A.,Christiansson Lisa H.,Thörn Ingrid,Mangsbo Sara,Paul-Wetterberg Gabriella,Sundström Christer,Tötterman Thomas H.,Simonsson Bengt,Enblad Gunilla,Frisk Per,Olsson-Strömberg Ulla,Loskog Angelica S.I.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2567.2011.03439.x/fullpdf

Reference58 articles.

1. Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer;Martorelli;Int Rev Immunol,2010

2. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells;Fontenot;Nat Immunol,2003

3. Control of regulatory T cell development by the transcription factor Foxp3;Hori;Science (New York, NY),2003

4. An essential role for Scurfin in CD4+ CD25+ T regulatory cells;Khattri;Nat Immunol,2003

5. Crucial role of FOXP3 in the development and function of human CD25+ CD4+ regulatory T cells;Yagi;Int Immunol,2004

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of Accumulation of Clonally Expanded and Senescent CD4 ⁺ GNLY ⁺ T Cells in Immunological Non-responders of HIV-1 infection;Emerging Microbes & Infections;2024-09-06

2. CXCR6 defines therapeutic subtypes of CD4+ cytotoxic T cell lineage for adoptive cell transfer therapy in pediatric B cell acute lymphoblastic leukemia;International Immunopharmacology;2024-05

3. Regulatory T cell niche in the bone marrow, a new player in Haematopoietic stem cell transplantation;Blood Reviews;2023-05

4. Characterization of post-vaccination SARS-CoV-2 T cell subtypes in patients with different hematologic malignancies and treatments;Frontiers in Immunology;2023-04-28

5. Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies;Frontiers in Immunology;2022-08-01